1. Home
  2. ALLR vs MSS Comparison

ALLR vs MSS Comparison

Compare ALLR & MSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • MSS
  • Stock Information
  • Founded
  • ALLR 2004
  • MSS 2019
  • Country
  • ALLR United States
  • MSS United States
  • Employees
  • ALLR N/A
  • MSS N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • MSS
  • Sector
  • ALLR Health Care
  • MSS
  • Exchange
  • ALLR Nasdaq
  • MSS Nasdaq
  • Market Cap
  • ALLR 21.8M
  • MSS 18.6M
  • IPO Year
  • ALLR N/A
  • MSS 2023
  • Fundamental
  • Price
  • ALLR $1.42
  • MSS $0.73
  • Analyst Decision
  • ALLR Strong Buy
  • MSS Strong Buy
  • Analyst Count
  • ALLR 1
  • MSS 1
  • Target Price
  • ALLR $9.25
  • MSS $4.25
  • AVG Volume (30 Days)
  • ALLR 327.2K
  • MSS 6.5M
  • Earning Date
  • ALLR 11-13-2025
  • MSS 09-22-2025
  • Dividend Yield
  • ALLR N/A
  • MSS N/A
  • EPS Growth
  • ALLR N/A
  • MSS N/A
  • EPS
  • ALLR N/A
  • MSS N/A
  • Revenue
  • ALLR N/A
  • MSS $123,204,523.00
  • Revenue This Year
  • ALLR N/A
  • MSS $4.08
  • Revenue Next Year
  • ALLR N/A
  • MSS $7.89
  • P/E Ratio
  • ALLR N/A
  • MSS N/A
  • Revenue Growth
  • ALLR N/A
  • MSS 70.01
  • 52 Week Low
  • ALLR $0.61
  • MSS $0.65
  • 52 Week High
  • ALLR $2.35
  • MSS $3.96
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 40.01
  • MSS 38.91
  • Support Level
  • ALLR $1.40
  • MSS $0.65
  • Resistance Level
  • ALLR $1.53
  • MSS $0.76
  • Average True Range (ATR)
  • ALLR 0.12
  • MSS 0.06
  • MACD
  • ALLR -0.03
  • MSS -0.02
  • Stochastic Oscillator
  • ALLR 1.49
  • MSS 20.69

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

About MSS Maison Solutions Inc.

Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.

Share on Social Networks: